CRISPR/Cas systems usher in a new era of disease treatment and diagnosis

The discovery and development of the CRISPR/Cas system is a milestone in precise medicine. CRISPR/Cas nucleases, base-editing (BE) and prime-editing (PE) are three genome editing technologies derived from CRISPR/Cas. In recent years, CRISPR-based genome editing technologies have created immense ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ruiting, Wang, Qin, She, Kaiqin, Lu, Fang, Yang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560888/
https://www.ncbi.nlm.nih.gov/pubmed/36239875
http://dx.doi.org/10.1186/s43556-022-00095-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560888/
https://www.ncbi.nlm.nih.gov/pubmed/36239875
http://dx.doi.org/10.1186/s43556-022-00095-y

Ejemplares similares